Pinnacle Financial Group, Inc.’s Gain Therapeutics GANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04K Buy
+600
New +$1.1K ﹤0.01% 2078

Other funds holding GANX

Pinnacle Financial Group, Inc.'s GANX Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Gain Therapeutics (GANX) in Q3 2026: 600 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings.

50 funds tracked by Wall St. Rank hold GANX as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 600 shares of Gain Therapeutics worth $1.04K as of Q3 2026.
  • Gain Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Gain Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2078 holding.
  • 50 funds tracked by Wall St. Rank held Gain Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.